OPENING REMARKS

Eric Fischer, Board on Biology, National Research Council

Patenting Research Tools and the Law

Rebecca Eisenberg, University of Michigan

What Should be Public and What Should be Private in Science and Technology?

Richard Nelson, Columbia University

Sharing Intellectual Property: Empirical Studies of Scientific Exchange Among Human Genome Researchers

Steven Hilgartner, Cornell University

CASE STUDY DISCUSSIONS

Recombinant DNA

Moderator: Sidney Winter, Wharton School of Business
Floyd Grolle, Stanford University
Lita Nelsen, Massachusetts Inst. Technology

Protein and DNA Sequencing

Moderator: Robert Cook-Deegan, National Research Council
Leroy Hood, University of Washington
Harry Osterman, LI-CORE, Inc.
Waclaw Szybalski, University of Wisconsin

Gene Fragments (ESTs)

Moderator: Gerald Rubin, UC-Berkeley
William Haseltine, Human Genome Sciences
Thomas Caskey, Merck Research Laboratories
James Sikela, University of Colorado

PCR and Taq Polymerase

Moderator: Barbara Mazur, DuPont Nemours Co.
Ellen Daniell, Roche Molecular Systems
Bernie Poiesz, University of Syracuse
Tom Gallegos, Oncorpharm

Research Tools in Drug Discovery

Moderator: William Comer, SIBIA Inc.
Bennett Shapiro, Merck Research Laboratories
Larry Respess, Ligand Pharmaceuticals, Inc.
James Wilson, Inst. for Human Genome Therapy

Case Study Summaries: Overview of Issues Raised in Case Studies

Janet Joy*, Board on Biology, National Research Council

PERSPECTIVES FROM DIFFERENT SECTORS

What practices have worked well? What have not ?

Moderator: Ronald Sederoff, North Carolina State University

University

Gerald Rubin, University of California at Berkeley
Lita Nelsen, Massachusetts Institute of Technology

Private Sector

Leon Rosenberg, Bristol-Myers Squibb
Thomas D'Alonzo, Genvec, Inc.

Government

Harold Varmus, National Institutes of Health

General Discussion

Moderator: Ronald Sederoff